# A Double-Blind, Placebo-Controlled Study of Aripiprazole Adjunctive to Antidepressant Therapy

> **NCT00683852** · PHASE3 · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 225 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** Aripiprazole 5mg
- **DRUG:** Aripiprazole 2mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00683852
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2009-09
- **Final completion:** 2009-09
- **Target enrollment:** 225 (ACTUAL)
- **Last updated:** 2017-07-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00683852

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00683852, "A Double-Blind, Placebo-Controlled Study of Aripiprazole Adjunctive to Antidepressant Therapy". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00683852. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*